tradingkey.logo
搜尋

Cybin Ord Shs

HELP
添加自選
8.870USD
+0.010+0.11%
收盤 11-13 16:00(美東)
705.96M總市值
虧損本益比TTM
盤後交易 16:16 (美東)8.810USD-0.040-0.45%

關於 Cybin Ord Shs 公司

Cybin Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company creates psychedelic-based therapeutics to address the unmet need for treatment options for people who suffer from mental health conditions. Its N, N-dimethyltryptamine (DMT) and dDMT programs create a dataset of systematic research on these psychedelic molecules. The Company is developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder, and CYB004, a proprietary deuterated dDMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. CYB003 moves to Phase III and CYB004 moves to Phase II.CYB005 is in Preclinical stage. It has an intellectual property portfolio in the psychedelic drug development sector with over 80 patents granted and over 230 patent applications pending. The Company operates in Canada, the United States, the United Kingdom, the Netherlands, and Ireland.

Cybin Ord Shs 簡介

公司代碼- -
公司名稱- -
上市日期- -
CEO- -
員工數量- -
證券類型- -
年結日- -
公司地址- -
城市- -
上市交易所- -
國家- -
郵編- -
電話- -
網址- -
公司代碼- -
上市日期- -
CEO- -

Cybin Ord Shs公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Paul Glavine
Mr. Paul Glavine
Non-Executive Director
Non-Executive Director
4.85M
+32.88%
Mr. Paul Glavine
Mr. Paul Glavine
Non-Executive Director
Non-Executive Director
4.85M
+32.88%
Mr. Paul Glavine
Mr. Paul Glavine
Non-Executive Director
Non-Executive Director
4.85M
+32.88%
Mr. Eric How-Lun So
Mr. Eric How-Lun So
Chairman Emeritus, Non-Executive Director
Chairman Emeritus, Non-Executive Director
4.77M
+33.35%
Mr. Eric How-Lun So
Mr. Eric How-Lun So
Chairman Emeritus, Non-Executive Director
Chairman Emeritus, Non-Executive Director
4.77M
+33.35%
Mr. Eric How-Lun So
Mr. Eric How-Lun So
Chairman Emeritus, Non-Executive Director
Chairman Emeritus, Non-Executive Director
4.77M
+33.35%
Mr. Gabriel Fahel
Mr. Gabriel Fahel
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
498.55K
+5.92%
Mr. Gabriel Fahel
Mr. Gabriel Fahel
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
498.55K
+5.92%
Mr. Gabriel Fahel
Mr. Gabriel Fahel
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
498.55K
+5.92%
Mr. Grant B. Froese
Mr. Grant B. Froese
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Paul Glavine
Mr. Paul Glavine
Non-Executive Director
Non-Executive Director
4.85M
+32.88%
Mr. Paul Glavine
Mr. Paul Glavine
Non-Executive Director
Non-Executive Director
4.85M
+32.88%
Mr. Paul Glavine
Mr. Paul Glavine
Non-Executive Director
Non-Executive Director
4.85M
+32.88%
Mr. Eric How-Lun So
Mr. Eric How-Lun So
Chairman Emeritus, Non-Executive Director
Chairman Emeritus, Non-Executive Director
4.77M
+33.35%
Mr. Eric How-Lun So
Mr. Eric How-Lun So
Chairman Emeritus, Non-Executive Director
Chairman Emeritus, Non-Executive Director
4.77M
+33.35%
Mr. Eric How-Lun So
Mr. Eric How-Lun So
Chairman Emeritus, Non-Executive Director
Chairman Emeritus, Non-Executive Director
4.77M
+33.35%

常見問題

Cybin Ord Shs的前五大股東是誰?

Cybin Ord Shs的前五大股東如下:Mr. Paul Glavine

有多少機構持有Cybin Ord Shs(HELP)的股份?

截至2026Q1,共有206家機構持有Cybin Ord Shs的股份,合計持有的股份價值約為31.10M,占公司總股份的60.23% 。與2025Q4相比,機構持股有所增加,增幅為-45829674.00。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有